XML 24 R16.htm IDEA: XBRL DOCUMENT v3.23.1
PUBLIC OFFERING AND PRIVATE PLACEMENT (Tables)
3 Months Ended
Mar. 31, 2023
Statement of Stockholders' Equity [Abstract]  
Schedule of Derivative Liabilities at Fair Value
The fair value of the warrants has been estimated with the following weighted-average assumptions, including the most sensitive input, volatility:
March 31, 2023December 31, 2022
Risk-free interest rate
3.80%4.1%
Volatility
109.00%102.00%
Expected term (years)
3.383.63
The following table reflects the fair value roll forward reconciliation of the Public Warrants liabilities for the period ended March 31, 2023:
(in thousands)Warrant Derivative Liability
Balance, December 31, 2022
$809 
Change in fair value(574)
Balance, March 31, 2023
$235 
Summary of Warrants Outstanding and Exercisable
A summary of warrants outstanding and exercisable as of March 31, 2023 is as follows:
Year IssuedWarrants Outstanding and ExercisableWeighted Average Remaining
Contractual Life
Weighted Average Exercise Price
(in years)(per share)
20195,750,000 3.38$13.00 
20204,149,378 2.60$6.50 
202011,659,752 $— 
20212,055,920 5.69$1.69 
2021220,129,210 $— 
33,744,260